180
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Elevated Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-2 in Malignant Pleural Effusion

, , , , , , , & show all
Pages 182-187 | Published online: 08 Jul 2009

  • Daughaday WH, Rotwein P. Insulin-like growth factors-I and II. Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocr Rev 1989; 10: 68.
  • Rosenfeld RG, Lamson GL, Pham H, et al. Insulin-like growth factor binding proteins. Recent Prog Horm Res 1990; 46:99-163.
  • Shimasaki S, Ling N. Identi? cation and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, and -6). Prog Growth Factor Res 1991; 3: 243 -66.
  • Clemmons DR. Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev 1997; 8: 45-62.
  • Rajaram S, Baylink DJ, Mohan S. Insulin-like growth factor-binding proteins in serum and other biological ? uids: regulation and functions. Endocr Rev 1997; 1: 801-31.
  • Baxter RC, Binoux MA, Clemmons DR, et al. Recommendations for nomenclature of the insulin-like growth factor binding proteins superfamily. J Clin Endocrinol 1998; 83: 3213.
  • Martin JL. IGFBPs down under. Trends Endocrinol Metab 2001;12:142-4.
  • Binoux MA, Roghani M, Hossenlopp P, Hardouin S, Gourmelen M. Molecular forms of human IGF binding proteins: physiological implications. Acta Endocrinol 1991; 124: 41 -7.
  • Light RW, Macgregor MI, Luchsinger PC. Pleural effusions: The diagnostic separation of transudates and exudates. Ann Intern Med 1972; 77: 507-13.
  • Macaulay VM. Insulin-like growth factors and cancer. Br J Cancer 1992; 65: 311 -20.
  • Nyman T, Pekonen F. The expression of insulin-like growth factors and their binding proteins in normalhuman lymphocytes. Acta Endocrinol 1993; 128: 168-72.
  • Tenshoff B, Blum WF, Wingen AM, Mehls O. Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2, and 3 in children with chronic renal failure: relationship to height and glomerular ? ltration rate. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. J Clin Endocrinol Metab 1995; 80: 2684 -91.
  • Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M. Analysis of serum insulin-like growth factor binding proteins using Western blotting: using the method for titration of binding proteins and competitive binding studies. Anal Biochem 1986; 154: 138 -43.
  • Kanety H, Madjar Y, Dagan Y, et al. Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer. Correlation with serum prostate speci? c antigen. J Clin Endocrinol Metab 1993; 77: 229-33.
  • Kanety H, Kattan M, Goldberg I, et al. Increased insulin-like growth factor binding protein-2 (IGFBP-2) gene expressionand protein production lead to high IGFBP-2 content in malignant ovarian cyst ? uid. Br J Cancer 1996; 73: 1069 -73.
  • Muller HL, Oh Y, Gargosky SE, Lehrnbecher T, Hinz RY, Rosenfeld RG. Concentration of IGFBP-3, IGF, and IGFBP-3 protease activity in cerebrospinal ? uid of children with leukemia, central nervous system tumor, or meningitis. J Clin Endocrinol Metab 1993; 77: 1113-9.
  • Yee D, Morales FR, Hamilton TC, Von Hoff DD. Expression of insulin-like growth factor I, its binding proteins, and its receptor in ovarian cancer. Cancer Res 1991; 51: 5107- 12.
  • Figueroa JA, Yee D. The insulin-like growth factor binding proteins (IGFBPs) in human breast cancer. Breast Cancer Res 1992;22:81-90.
  • Reeve JG, Payne JA, Bleehen NM. Production of immunoreactive insulin-like growth factor-I (IGF-1) and IGF-1 binding proteins by human lung tumours. Br J Cancer 1990; 61: 727 -31.
  • Reeve JG, Schwander J, Bleehen NM. IGFBP-2: an important regulator of IGF action in human lung tumours. Growth Regul 1993; 3: 82-4.
  • Elmlinger MW, Wimmer K, Biemer E, Blum WF, Ranke MB, Dannencker GE. Insulin-like growth factor binding protein 2 is differentially expressed in leukemic B- and T-cell line. Growth Regul 1996; 6: 152-7.
  • Flyubjerg A, Mogensen O, Mogensen B, Nielsen OS. Elevated serum IGBP-2 and decreased IGFPP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor-associated trypsin inhibitor. J Clin Endocrinol Metab 1997; 82: 2308 -12.
  • Le Bouc Y, Bellocq A, Philippe C, et al. Insulin-like growth factor and their binding proteins in pleural ? uid. Eur J Endocrinol 1997; 137: 467-73.
  • Oh Y, Muller HL, Lamson G, Rosenfeld RG. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. J Biol Chem 1993;268:14964-71.
  • Davies SC, Wass GAH, Ross RJM, et al. The induction of a speci? c protease for insulin-like growth factor binding protein-3 in the circulation during severe illness. J Endocrinol 1991;130:469-73.
  • Giudice LC, Farrell EM, Pham H, Lamson G, Rosenfeld RG. Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effect of a serum associated protease activity. J Clin Endocrinol Metab 1990; 70: 806 -16.
  • Holly JM, Maile LA, Cwyfan Hughes SC, Fernihough JK, Xu S. IGFBP proteases-physiology:pathophysiology. In: Takano K, Hizuka N, Takahashi SI, eds. Molecular mechanism to regulate the activities of insulin-like growth factors. Tokyo: Elsevier, 1997: 889-97.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.